OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 153 filers reported holding OCULAR THERAPEUTIX INC in Q1 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $8 | -99.6% | 3 | -99.3% | 0.00% | – |
Q3 2022 | $2,000 | -99.3% | 440 | -99.3% | 0.00% | – |
Q1 2022 | $302,000 | -4.4% | 61,043 | +35.0% | 0.00% | – |
Q4 2021 | $316,000 | -20.2% | 45,202 | +14.4% | 0.00% | – |
Q3 2021 | $396,000 | -25.1% | 39,510 | +6.0% | 0.00% | – |
Q2 2021 | $529,000 | -24.5% | 37,277 | -12.9% | 0.00% | – |
Q1 2021 | $701,000 | -47.8% | 42,797 | -34.1% | 0.00% | -100.0% |
Q4 2020 | $1,344,000 | +2257.9% | 64,955 | +349.9% | 0.00% | – |
Q1 2019 | $57,000 | -74.8% | 14,437 | -57.0% | 0.00% | – |
Q2 2018 | $226,000 | -1.7% | 33,567 | -5.2% | 0.00% | – |
Q1 2018 | $230,000 | +42.9% | 35,411 | -2.4% | 0.00% | – |
Q4 2017 | $161,000 | -89.4% | 36,300 | -85.2% | 0.00% | -100.0% |
Q3 2017 | $1,515,000 | +937.7% | 245,144 | +1452.0% | 0.00% | – |
Q2 2017 | $146,000 | +18.7% | 15,795 | +19.1% | 0.00% | – |
Q1 2017 | $123,000 | -72.4% | 13,262 | -75.1% | 0.00% | – |
Q4 2016 | $446,000 | +136.0% | 53,183 | +92.6% | 0.00% | – |
Q3 2016 | $189,000 | +119.8% | 27,614 | +58.2% | 0.00% | – |
Q2 2016 | $86,000 | -87.1% | 17,451 | -44.9% | 0.00% | -100.0% |
Q2 2015 | $667,000 | – | 31,681 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 5,618,424 | $46,801,000 | 100.00% |
Opaleye Management Inc. | 5,984,200 | $49,848,000 | 10.07% |
DELTEC ASSET MANAGEMENT LLC | 2,330,267 | $19,411,000 | 4.06% |
Corriente Advisors, LLC | 720,000 | $5,998,000 | 3.89% |
Versant Venture Management, LLC | 2,215,384 | $18,454,145,000 | 2.65% |
SV Health Investors, LLC | 312,068 | $2,600,000 | 1.80% |
Ikarian Capital, LLC | 2,055,977 | $17,126,000 | 1.36% |
EAM Global Investors LLC | 265,316 | $2,210,000 | 0.99% |
EAM Investors, LLC | 346,075 | $2,883,000 | 0.64% |
RA Capital Management | 2,727,272 | $22,718,000 | 0.44% |